MLchartDataset catalogue

zanamivir

Term · Oncology and biomedicine · MLC-T-ONC-009457

  1. A drug used to prevent and to treat influenza virus infections. It blocks the release of the virus from infected cells. It is a type of antiviral agent. Also called Relenza.

  2. A sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sialic acid residues in host cell membrane-bound glycoprotein receptors for influenza viruses, preventing the release of progeny viruses from host cell surfaces and, so, further viral replication.

Table 1. Record
IdentifierMLC-T-ONC-009457
FieldOncology and biomedicine
SynonymsRelenza
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009457",
  "term": "zanamivir",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug used to prevent and to treat influenza virus infections. It blocks the release of the virus from infected cells. It is a type of antiviral agent. Also called Relenza.",
    "A sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sialic acid residues in host cell membrane-bound glycoprotein receptors for influenza viruses, preventing the release of progeny viruses from host cell surfaces and, so, further viral replication."
  ],
  "synonyms": [
    "Relenza"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/zanamivir/"
}

Record 17,597 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.